Broadcom Q1 FY2026 — Record Revenue, AI Acceleration
Reported Mar 4, 2026 · After Market Close
Total Revenue
$19.31B
Est: $19.14B
+29% YoY · BEAT +$170M
Non-GAAP EPS
$2.05
Est: $2.02
BEAT · +$0.03
AI Semi Revenue
$8.4B
Guidance was $8.2B
+106% YoY · ABOVE guide
Free Cash Flow
$8.01B
41.6% FCF margin
$10.9B returned to holders
Key quote (Hock Tan): "AI revenue growth is accelerating — we expect AI semiconductor revenue to be $10.7 billion in Q2, with total Q2 revenue of $22 billion (+47% YoY). Our custom accelerator business grew 140% YoY in Q1." Management confirmed visibility of >$100B in AI chip revenue for 2027, backed by multi-year supply agreements through 2028. Infrastructure software (VMware) at +1% YoY remains the drag; however, Q2 guidance of +9% YoY suggests recovery. $10B share repurchase authorized. Dividend raised to $0.65/qtr (+10%).
Catalysts vs Risks · Forward 12M
🚀
Catalysts
Google + Anthropic multi-year deal (Apr 8). Expanded partnership for next-gen custom AI chips (TPUs) and compute capacity — directly named AVGO as supplier in Anthropic's Claude infrastructure ramp. Structurally locks in demand through 2028+.
$100B AI chip revenue in 2027. Management's stated target, backed by $73B in AI backlog recognized over the next 18 months. Represents 3× the Q1 FY26 annualized run rate (~$33.6B). Credible trajectory given +106% / +140% sequential acceleration.
Hyperscaler capex cycle still accelerating. Google, Meta, Microsoft and now Anthropic all increasing data center spend in 2026. AVGO is the primary custom XPU beneficiary — no comparable competitor at scale.
FCF machine: $32B annualized. Capital return of $10.9B in a single quarter ($7.8B buybacks + $3.1B dividends). At this rate, 10%+ of market cap returned annually.
VMware software re-rating. Q2 guide +9% YoY vs. Q1 +1% YoY. If VMware subscription model conversion accelerates, infrastructure software could become a re-rating catalyst in H2 FY26.
Non-AI semiconductor recovery. Enterprise networking, broadband, server storage all inflecting positive. Q2 non-AI guide +4% YoY — first sustained positive cycle after 18 months of inventory digestion.
⚠️
Risks
Customer concentration: 2-3 hyperscalers = ~60%+ AI revenue. Google is the largest AI customer by far. Any slowdown, platform shift, or internal chip development could materially hit AI revenue. Morningstar explicitly flags this as a primary risk.
TSMC capacity constraint flagged. AVGO warned TSMC's advanced packaging capacity is "maxed out." If supply can't keep pace with the +140% AI demand trajectory, revenue upside is capped. No near-term resolution — TSMC is not adding capacity overnight.
Gross margin compression. GM expected to decline 100bp+ sequentially in FY26 as AI mix shifts to lower-margin custom chips vs. software. EBITDA margin held by opex leverage, but GM is the structural tell.
Inventory days elevated. DSI at 68 days — highest in 2 years. Non-AI semi recovery is uneven. A demand pause from hyperscalers in AI (unlikely but possible) could rapidly flip this to a supply glut.
VMware integration risk & EBITDA dilution. Still absorbing $40B+ acquisition debt (D/E 0.83x). Any enterprise IT spending slowdown could pressure VMware's ramp to the promised $8.5B run-rate. Migration friction with existing customers remains a real variable.
Valuation overshoot risk post-deal spike. Today's +16.66% move takes AVGO to $350 — 81% of its 52W range. At trailing P/E 60x, any earnings guide-down or macro shock (tariff escalation, geopolitical risk) could compress to $270-290 rapidly. High beta (1.26) amplifies drawdowns.
Bottom Line · Investment Verdict
Analyst Rating Spectrum
STRONG SELL
REDUCE
HOLD
SELECTIVE BUY ◆
BUY
STRONG BUY
Thesis in one line
AVGO is the cleanest AI revenue play with real FCF — not narrative, actual cash. The Google/Anthropic deal today structurally validates the multi-year custom XPU moat. The debate is not growth; it's whether you're paying too much for it.
Valuation read at $350
EV/EBITDA at ~40x is within the 35-45x band. Fwd P/E at 23x is actually cheap vs. growth rate (PEG 0.57). The risk is a multiple re-rate on any demand scare — which, at $350, leaves limited margin of safety vs. the Dec'25 high of $414.
Entry discipline
Add in tranches, not all-in at $350 post-spike. Pullback to $305-315 (2× Q1 FCF support zone) would be more attractive. A position already held should be held / trimmed on further strength above $380. Do not chase the Google deal pop.
Key monitoring flags
Watch: Q2 AI revenue delivery vs. $10.7B guide (May 2026), TSMC advanced packaging allocation updates, non-GAAP gross margin trend (floor ~74%), and whether a 3rd hyperscaler (Meta, Apple, Microsoft) becomes a confirmed AVGO custom XPU customer.
73
/ 100 · Conviction
AVGO scores 73/100 — a Selective Buy with strong fundamentals and AI growth acceleration offset by elevated valuation post-spike and structural customer concentration. The Google + Anthropic multi-year deal announced today (Apr 8) is a genuine positive catalyst — it eliminates the demand uncertainty overhang on the custom XPU roadmap. However, buying at $350 after a +16.66% single-day move requires discipline: the stock has a proven history of violent reversals (−33% from Dec'25 peak to Feb'26 trough). Best risk-adjusted action: hold existing 55sh position, set a tranche add trigger at $305-310, monitor Q2 FY26 delivery in May. The $100B AI chip vision for 2027 is the real prize — the entry timing is the only negotiable variable.